Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Charles River Laboratories International Inc CRL

Technology Scientific & Technical Instruments
Charles River Laboratories International, Inc. provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions around the globe accelerate their research and drug development efforts. The Company's Research Models and Services segment is comprised of three businesses that provide foundational tools that enables its clients to discover new molecules: Research Models, Research Model Services, and Cell Solutions. Its Discovery and Safety Assessment segment provides regulated and non-regulated DSA services to support the research, development, and regulatory-required safety testing of potential new drugs, including therapeutic discovery and optimization plus in vitro and in vivo studies, laboratory support services, and strategic non-clinical consulting and program management to support product development. Its Manufacturing Solutions segment includes Microbial Solutions and Biologics Solutions.


NYSE:CRL - Post by User

Charles River Laboratories International Inc
<< Previous
 Bullboard Posts
User Avatar Image
(229)
•••
Post by whytestockson Aug 07, 2024 7:15pm
36 Views
Post# 36168562

Charles River Laboratories Announces Second-Quarter 2024 Res

Charles River Laboratories Announces Second-Quarter 2024 Res
Just In: $CRL Charles River Laboratories Announces Second-Quarter 2024 Results&#x2013; Second-Quarter Revenue of $1.03 Billion &#x2013; &#x2013; Second-Quarter GAAP Earnings per Share of $1.74 and Non-GAAP Earnings per Share of $2.80 &#x2013; &#x2013; Board Approves New Stock Repurchase Authorization of $1.0 Billion &#x2013; &#x2013; Revises 2024 Gu...CRL - Charles River Laboratories Announces Second-Quarter 2024 Results

<< Previous
 Bullboard Posts
Dealroom for high-potential pre-IPO opportunities